About Bioxyne
Bioxyne is a company based in Sydney (Australia) founded in 1997.. Bioxyne has completed 1 acquisition, including Breathe Life Sciences. Bioxyne offers products and services including APIs and Starting Materials, Consumer Health Products, and Investigational Medicines. Bioxyne operates in a competitive market with competitors including Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and One bio, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioxyne Limited
-
Annual Revenue
$19.54 M (USD)217.14as on Jun 30, 2025
-
Net Profit
$3.24 M (USD)136.87as on Jun 30, 2025
-
EBITDA
$2.97 M (USD)420.71as on Jun 30, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bioxyne
Bioxyne is a publicly listed company on the ASX with ticker symbol BXN in Australia, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bioxyne
Bioxyne offers a comprehensive portfolio of products and services, including APIs and Starting Materials, Consumer Health Products, and Investigational Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supplies raw materials for pharmaceuticals and wellness products.
Develops and sells global health items like CBD and supplements.
Focuses on psilocybin and MDMA for mental health treatments.
Funding Insights of Bioxyne
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Post-IPO - Bioxyne | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Bioxyne
Bioxyne has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Breathe Life Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Brand of cannabis medical, health, and wellness products
|
2021 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bioxyne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioxyne Comparisons
Competitors of Bioxyne
Bioxyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pendulum, The Good Bug, Harmless Harvest, OptiBiotix Health and One bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| domain | founded_year | HQ Location |
Synbiotic supplements and fermented products for gut health are provided.
|
|
| domain | founded_year | HQ Location |
Branded coconut water and probiotic beverages are manufactured and marketed.
|
|
| domain | founded_year | HQ Location |
Microbial strains are developed for treating human metabolic diseases.
|
|
| domain | founded_year | HQ Location |
Online tools for partner management and opportunity screening.
|
|
| domain | founded_year | HQ Location |
Probiotic strains for health solutions are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioxyne
Frequently Asked Questions about Bioxyne
When was Bioxyne founded?
Bioxyne was founded in 1997 and raised its 1st funding round 27 years after it was founded.
Where is Bioxyne located?
Bioxyne is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
What is the annual revenue of Bioxyne?
Annual revenue of Bioxyne is $19.54M as on Jun 30, 2025.
What does Bioxyne do?
Bioxyne (formerly called VRI Biomedical) is focussed on developing dietary supplements and functional foods for immune health and immunotherapy. It is developing its products through its proprietary probiotic, Lactobacillus fermentum technology which is supported by a manufacturing and distribution agreement with Chr. Hansen (Denmark). It also has a distribution agreement with Nu-Skin Enterprises (USA) and holds approximately 5 of the share capital of Mariposa Health, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD). Currently, Bioxyne markets two products, Progastrim for improved gut and Protract for atopic dermatitis.
Who are the top competitors of Bioxyne?
Bioxyne's top competitors include The Good Bug, Pendulum and OptiBiotix Health.
What products or services does Bioxyne offer?
Bioxyne offers APIs and Starting Materials, Consumer Health Products, and Investigational Medicines.
Is Bioxyne publicly traded?
Yes, Bioxyne is publicly traded on ASX under the ticker symbol BXN.
How many acquisitions has Bioxyne made?
Bioxyne has made 1 acquisition, including Breathe Life Sciences.
What is Bioxyne's ticker symbol?
The ticker symbol of Bioxyne is BXN on ASX.